Polycyclic pyrimidines as potassium ion channel modulators

Details for Australian Patent Application No. 2005232745 (hide)

Owner Astellas Pharma Inc. Icagen, Inc.

Inventors Suzuki, Takeshi; Wang, Xiadong; Moritomo, Ayako; Kubota, Hideki; Ishii, Takahiro; Seconi, Darrick; Kazami, JunIchi; Fulp, Alan Bradley; Spear, Kerry Leigh

Agent Spruson & Ferguson

Pub. Number AU-A-2005232745

PCT Pub. Number WO2005/099711

Priority 60/561,990 13.04.04 US

Filing date 13 April 2005

Wipo publication date 27 October 2005

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/099711 Priority application(s): WO2005/099711

11 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232748-R(-)-11-hydroxyaporphine derivatives and uses thereof

2005232732-Methods of using sustained release aminopyridine compositions